Abstract
The importance of T cells in controlling SARS-CoV-2 infections has been demonstrated widely, but insights into the quality of these responses are still limited due to technical challenges. Indeed, understanding the functionality of the T-cell receptor (TCR) repertoire of a polyclonal antigen-specific population still requires the tedious work of T-cell cloning or TCR re-expression and subsequent characterization. In this work, we show that it is possible to discriminate highly functional and bystander TCRs based on gene signatures of T-cell activation induced by recent peptide stimulation. SARS-CoV-2-specific TCRs previously identified by cytokine release after peptide restimulation and subsequent single-cell RNA sequencing were re-expressed via CRISPR-Cas9-mediated gene editing into a Jurkat-based reporter cell line system suitable for high-throughput screening. We could observe differences in SARS-CoV-2 epitope recognition as well as a wide range of functional avidities. By correlating these in vitro TCR engineered functional data with the transcriptomic profiles of the corresponding TCR-expressing parental T cells, we could validate that gene signatures of recent T-cell activation accurately identify and predict truly SARS-CoV-2-specific TCRs. In summary, this work paves the way for alternative approaches useful for the functional analysis of global antigen-specific TCR repertoires with largely improved throughput.
Funding Information
  • EIT Health CoViproteHCt (20877)
  • German National Network of University Medicine of the Federal Ministry of Education and Research [BMBF; NaFoUniMedCovid19, COVIM] (01KX2021)
  • Deutsche Forschungsgesellschaft (DFG; German Research Foundation) (SFB1321/1-329628492 [project P17], SFB-TRR 338/1 2021-452881907 [project A01])
  • Corona-Forschungsanträge (Fakultät für Medizin)
  • Boehringer Ingelheim Fonds

This publication has 54 references indexed in Scilit: